Emergent Technologies

access our innovation engine

  • who we are
  • what we do
  • why we do it
  • how we do it
  • contact
  • blog
  • current news

we fuel a chain of technological breakthroughs; we solve problems that matter.

pills_38036c

August 19, 2014 by Thomas Harlan

Why Do Drugs for Rare Disease Cost So Much?

High prices for drugs to treat rare diseases continue to climb. It’s a bit like bad weather – people complain about it, but no one … [Read more...]

Filed Under: Pharmaceutical Research Tagged With: drug research, enzyme replacement therapy, Gattex, Joshua P Cohen, metabolic disorder, Ph.D., Tuts Center for the Study of Drug Development

our blog

The Business of Innovation

All Articles

Recent Articles

We’re Helping Bring A New “Super Sustainable” Fabric To Market. Here’s Why It Could Be A Game-Changer.

September 18, 2015

Pure MHC to Participate in Conference On Vaccine Research

August 19, 2015

Annual BIO Exhibition Brings Industry’s Greatest Minds Together. And Attracts Many Of Them To Emergent Portfolio Companies.

June 10, 2015

Emergent Technologies

7500 Rialto Blvd.
Bldg. 2, Ste. 260
Austin, Texas 78735

© 2015 | All Rights Reserved.

Who We Are
Management
Board of Directors
What We Do
Portfolio Companies
Partner Solutions
News
Why We Do It
Infinite Opportunities
Our Mission
How We Do It
Our Methodology
Tech Access Model
Contact
Blog